Sensus Healthcare Inc expected to post a loss of 1 cent a share - Earnings Preview

Sensus Healthcare

13/11/2024 24:04

* Sensus Healthcare Inc  SRTS.OQ   SRTS.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
14 for the period ending September 30 2024
    * The Boca Raton Florida-based  company is expected to
report a
51.2% increase in revenue to $5.895 million from $3.9 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Sensus Healthcare Inc is
for a
loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensus
Healthcare
Inc is $10.00​, above​ its last closing price of $7.15. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.02        0.02       0.10      Beat    328.6
 Mar. 31 2024  -0.06       -0.05      0.14      Beat    354.5
 Dec. 31 2023  0.14        0.12       0.26      Beat    113.1​
 Sep. 30 2023  -0.01       -0.02      -0.09     Missed  -400
 ​​Jun.        -0.08       -0.08      -0.02     Beat    73.7
 30 2023                                                
 Mar. 31 2023  0.12        0.13       -0.12     Missed  -193.7
                                                        ​
 Dec. 31 2022  0.25        0.23       0.17      Missed  -26.1
 Sep. 30 2022  0.12        0.13       0.11      Missed  -12.7
 This summary was machine generated November 13 at 00:04 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)